Synthesis, structure and quantitative structure-activity relationships of σ receptor ligands, 1-[2-(3,4-dimethoxyphenyl)ethyl]-4-(3-phenylpropyl)piperazines

Bioorganic and Medicinal Chemistry

Volumn 5, Issue 8, 1997, Pages 1675-1683

  Fujimura, Ken Ichi ^a   Matsumoto, Junzo ^a   Niwa, Masashi ^a   Kobayashi, Tadayuki ^a   Kawashima, Yoichi ^b   In, Yasuko ^c   Ishida, Toshimasa ^c  

^a Developmental Research Division   (Japan)

^b SANTEN PHARMACEUTICAL CO LTD   (Japan)

^c OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE RECEPTOR AFFECTING AGENT; SIGMA OPIATE RECEPTOR;

ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; QUANTITATIVE STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

ANALGESICS, OPIOID; ANTICONVULSANTS; CRYSTALLOGRAPHY, X-RAY; GUANIDINES; LIGANDS; MOLECULAR WEIGHT; PENTAZOCINE; PIPERAZINES; RECEPTORS, SIGMA; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0030843039     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(97)00093-X     Document Type: Article

References (39)

1. (a) Roman, F.; Pascaud, X.; Vauché, D.; Junien, J. L. Life Sciences, 1988, 42, 2217.
2. (b) Roman, F.; Pascaud, X.; Chomette, G.; Bueno, L.; Junien, J. L. Gastroenterology, 1989, 97, 76.
3. Roman, F. J.; Pascaud, X.; Salmon, R.; Chomette, G.; Junien, J. L. Gastroenterology, 1991, 100, A662.
4. (a) Wolfe, S. A. Jr.; De Souza, E. B. In Sigma Receptors; Itzhak, Y., Ed.; Academic: London, 1994; pp 287.
5. (b) Carr, D. J. J.; Costa, B. R. D.; Radesca, L.; Blalock, J. E. J. Neuroimmunol. 1991, 35, 153.
6. Jansen, K. L. R.; Faull, R. L. M.; Dragunow, M.; Leslie, R. A. Brain Res. 1991, 559, 172.
7. Jansen, K. L. R.; Faull, R. L. M.; Storey, P.; Leslie, R. A. Brain Res. 1993, 623, 299.
8. (a) Largent, B. L.; Winkström, H.; Snowman, A. M.; Snyder, S. H. Eur. J. Pharmacol. 1987, 155, 345.
9. (b) Snyder, S. H.; Largent, B. L. J. Neuropsychiatry 1989, 1, 7.
10. Matsuno, K.; Nakazawa, M.; Okamoto, K.; Kawashima, Y.; Mita, S. Eur. J. Pharmacol. 1996, 306, 271.
11. Kobayashi, T.; Matsuno, K.; Nakata, K.; Mita, S. J. Pharmacol. Exp. Ther. 1996, 279, 106.
12. Shiozawa, A.; Ichikawa, Y.; Komuro, C.; Idzu, G.; Ishikawa, M.; Kurashige, S.; Miyazaki, H.; Yamanaka, H.; Sakamoto, T. Chem. Pharm. Bull. 1984, 32, 553.
13. Danso-Danquah, R.; Bai, X.; Zhang, X.; Mascarella, S. W.; Williams, W.; Sine, B.; Bowen, W. D.; Caroll, F. I. J. Med. Chem. 1995, 38, 2978.
14. Glennon, R. A.; Ismaiel, A. M.; Smith, J. D.; Yousif, M.; El-Ashmawy, M. B.; Herndon, J. L.; Fisher, J. B.; Howie, K. B.; Server, A. C. J. Med. Chem. 1991, 34, 1855.
15. Zhang, Y; Williams, W.; Bowen, W. D.; Rice, C. J. Med. Chem. 1996, 39, 3564.
16. He, X.-s.; Bowen, W. D.; Lee, K. S.; Williams, W.; Weinberger, D. R.; de Costa, B. R. J. Med. Chem. 1993, 36, 566.
17. (a) Swain, C. G.; Lupton, E. C. Jr. J. Am. Chem. Soc. 1968, 90, 4328.
18. (b) Hansch, C.; Leo, A.; Unger, S. H.; Kim, K. H.; Nikaitani, D.; Lien, E. J. J. Med. Chem. 1973, 16, 1207.
19. Hansch, C.; Rockwell, S. D.; Jow, P. Y. C.; Leo, A.; Steller, E. E. J. Med. Chem. 1977, 20, 304.
20. 15 However, even with the R value of -0.6, a good correlation (r = 0. 977) was obtained and thus supports this trend.
21. Hansch, C.; Leo, A.; Taft, R. W. Chem. Rev., 1991, 91, 165.
22. Hansch, C.; Leo, A. In Exploring QSAR (Fundamentals and Applications in Chemistry and Biology); Heller, S. R., Ed.; American Chemical Society: Washington D.C., 1995; p 14.
23. (a) Yukawa, Y.; Tsuno, Y.; Sawada, M. Bull. Chem. Soc. Japan 1966, 39, 2274.
24. (b) Yukawa, Y.; Tsuno, Y.; Sawada, M. Bull. Chem. Soc. Japan 1972, 45, 1198.
25. Yukawa, Y.; Tsuno, Y. Bull. Chem. Soc. Japan 1959, 32, 965.
26. Yukawa, Y.; Tsuno, Y. Bull. Chem. Soc. Japan 1959, 32, 971.
27. Molecular Simulations, 9685 Scranton Road, San Diego, CA 92121-3752, U.S.A.
28. (a) Gilligan, P. J.; Cain, G. A.; Christos, T. E.; Cook, L.; Drummond, S.; Johnson, A. L.; Kergaye, A. A.; McElroy, J. F.; Rohrbach, K. W.; Schmidt, W. K.; Tam, S. W. J. Med. Chem. 1992, 35, 4344.
29. (b) Glennon, R. A.; Ablordeppy, S. Y.; Ismaiel, A. M.; El-Ashmawy, M. B.; Fisher, J. B.; Howie, K. B. J. Med. Chem. 1994, 37, 1214.
30. Abraham, D. J.; In Computer-Aided Drug Design, Methods and Applications; Perun, T. J; Propst, C. L., Eds; Marcel Dekker: New York, 1989; p 104.
31. (a) Sotomatsu, T.; Murata, Y.; Fujita, T. J. Comput. Chem. 1989, 10, 94.
32. (b) Kim, K. H.; Martin, Y. C. J. Org. Chem. 1991, 56, 2723.
33. (a) Herbert, R. B.; Kattah, A. E. Tetrahedron 1990, 20, 7105.
34. (b) Ronald, R. C.; Wheeler, C. J. J. Org. Chem. 1984, 49, 1685.
35. Shiozawa, A.; Ichikawa, Y.; Komuro, C.; Idzu, G.; Ishikawa, M.; Kurashige, S.; Miyazaki, H.; Yamanaka, H.; Sakamoto, T. Chem. Pharm. Bull. 1984, 32, 553.
36. Debaerdemaeker, T.; Germain, G.; Main, P.; Tate, C.; Wollfson, M. M. A System of Computer Programs for the Atomic Solution of Crystal Structure from X-Ray Diffraction Data; University of York, U.K., Louvain, Belgium, 1987.
37. The Universal Crystallographic Computing System - Osaka; The Computation Center, Osaka University, Japan, 1979.
38. (a) Stewart, J. J. P. J. Comput. Chem. 1989, 10, 209.
39. (b) Stewart, J. J. P. J. Comput. Chem. 1989, 10, 221.